The underrepresentation in clinical trials of specific populations, such as racial and ethnic minorities, women, the elderly, disabled persons and those living in rural populations, is at direct odds with the current state of medical science and drug discovery, which is increasingly moving closer to personalized medicine, a group of researchers and physicians known as the Eliminating Disparities in Clinical Trials (EDICT) argued in a new report. Yet, they said, despite years of discussion and the implementation of federal and state policies and guidelines to prevent such exclusions, the problem persists, mostly due to the fact that most clinical trials are funded by drug-makers, which …
No comments:
Post a Comment